<DOC>
	<DOCNO>NCT01586091</DOCNO>
	<brief_summary>Primary objective : The comparative efficacy levocetirizine 5 mg daily fexofenadine 60 mg twice daily histamine induced wheal , flare itch response measure 0 ( baseline ) , 0.5 , 1 , 2 , 3 , 4 , 6 , 8 , 10 , 12 24 hour . Secondary objective : 1 . The area curve ( 0 , 12 hour , 12 - 24 hour 0 - 24 hour ) inhibition histamine induce wheal , flare itch response levocetirizine 5 mg daily fexofenadine 60 mg twice daily . 2 . The number individual peak response 10 percentile ( Because variable absorption fexofenadine , predict fexofenadine variable response individual ) . 3 . The mean plasma level levocetirizine fexofenadine 0 ( baseline ) , 0.5 , 1 , 2 , 3 , 4 , 6 , 8 , 10 , 12 24 hour .</brief_summary>
	<brief_title>Safety Study Levocetirizine Fexofenadine</brief_title>
	<detailed_description />
	<mesh_term>Rhinitis , Allergic</mesh_term>
	<mesh_term>Rhinitis</mesh_term>
	<mesh_term>Levocetirizine</mesh_term>
	<mesh_term>Cetirizine</mesh_term>
	<mesh_term>Fexofenadine</mesh_term>
	<mesh_term>Terfenadine</mesh_term>
	<criteria>Eighteen ( 18 ) healthy male volunteer , include least 6 person Japanese origin , recruit study None subject take oral antihistamine , antidepressant , antipsychotic corticosteroid apply topical antihistamine , corticosteroid mast cell stabilizer skin 2 week prior test . No subject shall perform physical exercise 4 hour prior skin prick testing . Especially , Bronchial asthma , anaphylactic reaction history , use betablockers , skin disease test field exclusion criterion .</criteria>
	<gender>Male</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>April 2012</verification_date>
</DOC>